News

COVID-19 Clinical Trials Suffer from Racial Disproportionality

Written by Yourway | August 20, 2020

Initial findings have revealed that there is an underrepresentation of minority groups in COVID-19 clinical trials. Two early studies have failed to either provide equal representation of Black, Latinx, and Native Americans or have yet to release data on sex or gender, race, and ethnicity. Headquartered in Allentown, Pennsylvania, Yourway has access to all major cities in the United States. We also offer direct-to-patient trials services, available 24/7, which may help many participants overcome challenges in accessing trials and could be of substantial benefit to traditionally underrepresented communities.